Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
October 31, 2023 at 11:59 AM EDT
Amgen Inc.'s stock fell 3.3% Tuesday despite an earnings beat and raised guidance. Obesity drugs were to blame.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Events | Directory | Real Estate | Blog | More
|